Paget Disease of Bone.
Mamun Al-Rashid1, Dipak B Ramkumar2, Kevin Raskin3
1Orthopaedic Oncology Service, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA; Orthopaedic Oncology Service, Department of Orthopaedic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA.
Paget disease of bone (PDB) management has evolved, with surgery reserved for specific complications. While treatments improve function, a small percentage of patients may still develop Paget sarcoma.
Area of Science:
- Orthopedics
- Bone Metabolism
- Skeletal Pathologies
Background:
- Paget disease of bone (PDB) understanding has significantly advanced since its initial description in 1877.
- Medical management is the primary treatment approach for PDB.
- Surgical interventions for PDB are typically reserved for specific complications and advanced cases.
Purpose of the Study:
- To provide an overview of the current understanding and management of Paget disease of bone.
- To highlight the role of surgical interventions in managing PDB complications.
- To acknowledge the risk of Paget sarcoma in a subset of PDB patients.
Main Methods:
- Review of historical and current medical literature on Paget disease of bone.
- Analysis of indications for surgical intervention in PDB.
- Discussion of advancements in surgical techniques and outcomes.
Main Results:
- Medical management remains the cornerstone of PDB treatment.
- Surgical interventions are indicated for fractures, deformities, impending fractures, severe arthritis, and neural compression.
- Surgical advancements facilitate earlier patient mobilization and functional recovery.
Conclusions:
- Paget disease of bone management has evolved, integrating medical and surgical approaches.
- While effective, current treatments do not eliminate the risk of developing Paget sarcoma in a small patient subset.
- Continued research and advancements are crucial for improving PDB patient outcomes.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
Bone Remodeling
Spongy Bone
Spongy bone is more porous, and less dense compared to compact bone. It is composed of concentric lamellae that are arranged irregularly to form the trabecular network. In some bones, the spaces between trabeculae contain red marrow, where...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Formation by Endochondral Ossification


